JENNIFER RYDER: Open Payments
NPI 1386191914 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 49 payments from 12 companies in 2025. Trend: 2023 $691 · 2024 $1,139 · 2025 $697
Food & beverage: $652Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $168 |
| Novo Nordisk Inc | 12 | $143 |
| Lilly USA, LLC | 8 | $138 |
| Amgen Inc. | 3 | $50 |
| Currax Pharmaceuticals LLC | 3 | $47 |
| PFIZER INC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Abbott Laboratories | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Wegovy, VRAYLAR, MOUNJARO, CONTRAVE, QULIPTA, OTEZLA, NURTEC ODT, FREESTYLE LIBRE 3.
Industry payments across AL — which companies pay providers there.
